Biomarkers of type 2 and non-type 2 inflammation in asthma exacerbations.
- Published in:
- Central European Journal of Immunology, 2024, v. 49, n. 2, p. 203, doi. 10.5114/ceji.2024.141345
- By:
- Publication type:
- Article
Works matching IS 14263912 AND DT 2024 AND VI 49 AND IP 2
Results: 13
1
2
Transcriptome analysis of anaerobic glycolysis effects on Jurkat T cell proliferation.
- Published in:
- Central European Journal of Immunology, 2024, v. 49, n. 2, p. 194, doi. 10.5114/ceji.2024.142116
- By:
- Publication type:
- Article
3
The effect of periodontal health and disease on interleukin 1β and nesfatin-1 levels in gingival crevicular fluid: A cross-sectional study.
- Published in:
- Central European Journal of Immunology, 2024, v. 49, n. 2, p. 187, doi. 10.5114/ceji.2024.140637
- By:
- Publication type:
- Article
4
Preventive effect of hyperforin on lipopolysaccharide-induced acute kidney injury and inflammation by repressing the NF-κB/miR-21 axis.
- Published in:
- Central European Journal of Immunology, 2024, v. 49, n. 2, p. 169, doi. 10.5114/ceji.2024.140636
- By:
- Publication type:
- Article
5
CSF3R as a potential prognostic biomarker and immunotherapy target in glioma.
- Published in:
- Central European Journal of Immunology, 2024, v. 49, n. 2, p. 155, doi. 10.5114/ceji.2024.140651
- By:
- Publication type:
- Article
6
Progression patterns in patients with advanced hepatocellular carcinoma treated with local therapy, targeted drugs, and PD-1/PD-L1 inhibitors.
- Published in:
- Central European Journal of Immunology, 2024, v. 49, n. 2, p. 147, doi. 10.5114/ceji.2024.142418
- By:
- Publication type:
- Article
7
Targeting the serum marker interleukin 9 improves the underlying characterization and immune homeostasis in rheumatoid arthritis.
- Published in:
- Central European Journal of Immunology, 2024, v. 49, n. 2, p. 132, doi. 10.5114/ceji.2024.141695
- By:
- Publication type:
- Article
8
Risk factors of thyroid dysfunction in patients with rheumatoid arthritis.
- Published in:
- Central European Journal of Immunology, 2024, v. 49, n. 2, p. 126, doi. 10.5114/ceji.2024.140634
- By:
- Publication type:
- Article
9
Apurinic/apyrimidinic endonuclease 1 alleviates inflammation in fibroblast-like synoviocytes from patients with rheumatoid arthritis.
- Published in:
- Central European Journal of Immunology, 2024, v. 49, n. 2, p. 113, doi. 10.5114/ceji.2024.141946
- By:
- Publication type:
- Article
10
Changes in immune status of circulating NK cells in patients with latent tuberculosis infection.
- Published in:
- Central European Journal of Immunology, 2024, v. 49, n. 2, p. 105, doi. 10.5114/ceji.2024.142104
- By:
- Publication type:
- Article
11
Comparison of cytotoxicity methods for studying Vipera ammodytes venom and the anticytotoxic potency of antivenom.
- Published in:
- Central European Journal of Immunology, 2024, v. 49, n. 2, p. 94, doi. 10.5114/ceji.2024.142417
- By:
- Publication type:
- Article
12
A case of trigeminal neuralgia that occurred after COVID-19 vaccination.
- Published in:
- Central European Journal of Immunology, 2024, v. 49, n. 2, p. 92, doi. 10.5114/ceji.2024.142414
- By:
- Publication type:
- Article
13
Exploring the role of hyperforin in modulating the NF-κB/miR-21 axis in sepsis-induced acute kidney injury.
- Published in:
- Central European Journal of Immunology, 2024, v. 49, n. 2, p. 91, doi. 10.5114/ceji.2024.142413
- By:
- Publication type:
- Article